XML 159 R135.htm IDEA: XBRL DOCUMENT v3.24.0.1
Related Parties (Details) - USD ($)
$ in Thousands
12 Months Ended
Apr. 20, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Jul. 24, 2020
Related Party Transaction [Line Items]          
Equity method investments         $ 4,900
Share of losses from equity method investments   $ 383 $ 3,136 $ 2,161  
Goodwill   9,022,075 8,971,670 9,037,931  
Acquisition related costs   $ 6,160 0 0  
Oncacare          
Related Party Transaction [Line Items]          
Percentage of share capital acquired 51.00%        
Business combination, consideration transferred $ 5,100        
Goodwill 13,400        
Acquisition related costs $ 6,200        
Oncacare          
Related Party Transaction [Line Items]          
Equity method investments         $ 4,900
Equity method investment, ownership percentage   49.00%     49.00%
Share of losses from equity method investments   $ 400 3,100 $ 2,200  
Corvus Pharmaceuticals | Subsidiaries          
Related Party Transaction [Line Items]          
Revenues   243 428    
Other receivables   101 231    
Afimmune Limited | Subsidiaries          
Related Party Transaction [Line Items]          
Revenues   45 235    
Other receivables   $ 47 $ 263